Evidence map›Paper›PMID 36722473›Full record

ArticleAnnals of the New York Academy of Sciences2023

Respiratory viruses: New frontiers-a Keystone Symposia report.

Jennifer Cable, Jie Sun, In Su Cheon, Andrew E Vaughan, Italo A Castro, Sydney R Stein, Carolina B López, Katelyn M Gostic, Peter J M Openshaw, Ali H Ellebedy and 17 more

Open access · greenAbstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of the New York Academy of Sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 6 countries.

Jennifer CablePhD Science Writer, New York, New York, USA.
Jie SunDivision of Pulmonary and Critical Medicine, Department of Medicine; Department of Immunology; and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.
In Su CheonDivision of Pulmonary and Critical Medicine, Department of Medicine; Department of Immunology; and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.
Andrew E VaughanUniversity of Pennsylvania School of Veterinary Medicine, Biomedical Sciences, Philadelphia, Pennsylvania, USA.
Italo A CastroVirology Research Center, Ribeirao Preto Medical School, University of São Paulo - USP, São Paulo, Brazil.
Sydney R SteinEmerging Pathogens Section, Critical Care Medicine Department, Clinical Center and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Carolina B LópezDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Katelyn M GosticDepartment of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA.
Peter J M OpenshawDepartment of Respiratory Medicine, Imperial College London, London, UK.
Ali H EllebedyDepartment of Pathology and Immunology; The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs; and Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, Missouri, USA.
Andreas WackImmunoregulation Laboratory, The Francis Crick Institute, London, UK.
Edward HutchinsonMRC - University of Glasgow Centre for Virus Research, Glasgow, UK.
Mallory M ThomasMontana State University, Bozeman, Montana, USA.
Ryan A LangloisCenter for Immunology and Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Daniel LingwoodThe Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
Steven F BakerLovelace Biomedical Research Institute, Albuquerque, New Mexico, USA.
Melanie FolkinsDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Ellen F FoxmanDepartment of Laboratory Medicine and Department of Immunology, Yale University School of Medicine, New Haven, Connecticut, USA.
Andrew B WardDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Martin SchwemmleInstitute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Alistair B RussellDivision of Biological Sciences, University of California, San Diego, La Jolla, California, USA.
Christopher ChiuDepartment of Infectious Disease, Imperial College London, London, UK.
Ketaki GantiDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Kanta SubbaraoDepartment of Microbiology and Immunology, WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Timothy P SheahanDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pablo Penaloza-MacMasterDepartment of Microbiology-Immunology, School of Medicine, Northwestern University Feinberg, Chicago, Illinois, USA.
Taylor EddensPediatric Scientist Development Program, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Carter Center · USEmory University · USImmune Regulation (United Kingdom) · GBImperial College London · GBLovelace Respiratory Research Institute · USMayo Clinic in Arizona · USMontana State University · USMRC University of Glasgow Centre for Virus Research · GBNational Institute of Allergy and Infectious Diseases · USNIHR Imperial Biomedical Research Centre · GBNorthwestern University · USPeter Doherty Institute · AURagon Institute of MGH, MIT and Harvard · USScripps Research Institute · USThe Francis Crick Institute · GBUniversidade de São Paulo · BRUniversity of Alberta · CAUniversity of California, San Diego · USUniversity of Chicago · USUniversity of Freiburg · DE

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)U01AI144616 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GORDON, AUBREE L, THOMAS, PAUL G. · 2019 to 2025
$43.7M
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSESU01AI150747 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2020 to 2024
$5.9M
Programming Durable Immune Responses To VaccinationU01AI141990 · NIAID · WASHINGTON UNIVERSITY · PI Ali Hassan Ellebedy · 2019 to 2026
$5.3M
Structural interrogation of vaccine- and infection-induced B cell responsesR01AI168178 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Goran Bajic · 2022 to 2026
$3.9M
Host response-based screening for unexpected or emerging respiratory virusesR21AI156208 · NIAID · YALE UNIVERSITY · PI FOXMAN, ELLEN FLESCHER · 2021 to 2022
$461k
Medical Research Council CC2085Medical Research Council MC_PC_19026Medical Research Council MC_U117597139Medical Research Council MC_UU_00034/1Medical Research Council MC_UU_12014/9Medical Research Council MR/N008618/1Medical Research Council MR/R005982/1Medical Research Council MR/R502121/1Medical Research Council MR/V035789/1NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI168178NIAID NIH HHS R21 AI156208NIAID NIH HHS U01 AI141990NIAID NIH HHS U01 AI144616NIAID NIH HHS U01 AI150747Wellcome Trust 087805/Z/08/ZWellcome Trust CC2085
6 · The paper itself

Abstract

Respiratory viruses are a common cause of morbidity and mortality around the world. Viruses like influenza, RSV, and most recently SARS-CoV-2 can rapidly spread through a population, causing acute infection and, in vulnerable populations, severe or chronic disease. Developing effective treatment and prevention strategies often becomes a race against ever-evolving viruses that develop resistance, leaving therapy efficacy either short-lived or relevant for specific viral strains. On June 29 to July 2, 2022, researchers met for the Keystone symposium "Respiratory Viruses: New Frontiers." Researchers presented new insights into viral biology and virus-host interactions to understand the mechanisms of disease and identify novel treatment and prevention approaches that are effective, durable, and broad.

Indexed as

COVID-19Influenza, HumanRespiratory Syncytial Virus InfectionsHost Microbial InteractionsHumansRespiratory Syncytial VirusesSARS-CoV-2adaptive immunityCOVID-19influenza virusinnate immunityrespiratory virusRSV

Identifiers

PMID36722473
PMCPMC10580159
OpenAlexW4318754679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.